129 related articles for article (PubMed ID: 36584916)
1. The overexpressed regucalcin represses the growth via regulating diverse pathways linked to EGF signaling in human ovarian cancer SK-OV-3 cells: Involvement of extracellular regucalcin.
Yamaguchi M; Murata T; Ramos JW
Life Sci; 2023 Feb; 314():121328. PubMed ID: 36584916
[TBL] [Abstract][Full Text] [Related]
2. Prolonged survival of patients with colorectal cancer is associated with a higher regucalcin gene expression: Overexpression of regucalcin suppresses the growth of human colorectal carcinoma cells in vitro.
Yamaguchi M; Osuka S; Murata T
Int J Oncol; 2018 Sep; 53(3):1313-1322. PubMed ID: 29956741
[TBL] [Abstract][Full Text] [Related]
3. Extracellular regucalcin suppresses colony formation and growth independent of tumor suppressor p53 in human mammary epithelial cells.
Yamaguchi M; Murata T
Tissue Cell; 2020 Dec; 67():101447. PubMed ID: 33137709
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of regucalcin blocks the migration, invasion, and bone metastatic activity of human prostate cancer cells: Crosstalk between cancer cells and bone cells.
Yamaguchi M; Murata T; Ramos JW
Prostate; 2022 Jun; 82(10):1025-1039. PubMed ID: 35365850
[TBL] [Abstract][Full Text] [Related]
5. The overexpressed transcription factor RGPR-p117 suppresses the proliferation of normal rat kidney proximal tubular epithelial NRK-52E cells: Involvement of diverse signaling pathways.
Yamaguchi M; Ghanem NZ; Hashimoto K; Ramos JW; Murata T
Life Sci; 2022 Oct; 306():120795. PubMed ID: 35835253
[TBL] [Abstract][Full Text] [Related]
6. Prolonged survival of renal cancer patients is concomitant with a higher regucalcin gene expression in tumor tissues: Overexpression of regucalcin suppresses the growth of human renal cell carcinoma cells in vitro.
Yamaguchi M; Osuka S; Hankinson O; Murata T
Int J Oncol; 2019 Jan; 54(1):188-198. PubMed ID: 30387835
[TBL] [Abstract][Full Text] [Related]
7. The inflammatory macrophages repress the growth of bone metastatic human prostate cancer cells via TNF-α and IL-6 signaling: Involvement of cell signaling regulator regucalcin.
Yamaguchi M; Hashimoto K; Jijiwa M; Murata T
Cell Signal; 2023 Jul; 107():110663. PubMed ID: 37001596
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of regucalcin suppresses cell proliferation in cloned rat hepatoma H4-II-E cells: involvement of intracellular signaling factors and cell cycle-related genes.
Yamaguchi M; Daimon Y
J Cell Biochem; 2005 Aug; 95(6):1169-77. PubMed ID: 15962315
[TBL] [Abstract][Full Text] [Related]
9. Extracellular Regucalcin Suppresses the Growth, Migration, Invasion, and Adhesion of Metastatic Human Prostate Cancer Cells.
Yamaguchi M; Murata T; Ramos JW
Oncology; 2022; 100(7):399-412. PubMed ID: 35340010
[TBL] [Abstract][Full Text] [Related]
10. Progression-free survival of prostate cancer patients is prolonged with a higher regucalcin expression in the tumor tissues: Overexpressed regucalcin suppresses the growth and bone activity in human prostate cancer cells.
Yamaguchi M; Osuka S; Murata T; Ramos JW
Transl Oncol; 2021 Jan; 14(1):100955. PubMed ID: 33232921
[TBL] [Abstract][Full Text] [Related]
11. Ursolic acid from Oldenlandia diffusa induces apoptosis via activation of caspases and phosphorylation of glycogen synthase kinase 3 beta in SK-OV-3 ovarian cancer cells.
Song YH; Jeong SJ; Kwon HY; Kim B; Kim SH; Yoo DY
Biol Pharm Bull; 2012; 35(7):1022-8. PubMed ID: 22791147
[TBL] [Abstract][Full Text] [Related]
12. Prolonged survival in pancreatic cancer patients with increased regucalcin gene expression: Overexpression of regucalcin suppresses the proliferation in human pancreatic cancer MIA PaCa-2 cells in vitro.
Yamaguchi M; Osuka S; Weitzmann MN; El-Rayes BF; Shoji M; Murata T
Int J Oncol; 2016 May; 48(5):1955-64. PubMed ID: 26935290
[TBL] [Abstract][Full Text] [Related]
13. Physcion-8-O-β-d-glucoside interferes with the nuclear factor-κB pathway and downregulates P-glycoprotein expression to reduce paclitaxel resistance in ovarian cancer cells.
Li X; He Y; Wei L; Zhang J; Li X; Cui W; Zhang S
J Pharm Pharmacol; 2021 Mar; 73(4):545-552. PubMed ID: 33793827
[TBL] [Abstract][Full Text] [Related]
14. Increased regucalcin gene expression extends survival in breast cancer patients: Overexpression of regucalcin suppresses the proliferation and metastatic bone activity in MDA-MB-231 human breast cancer cells in vitro.
Yamaguchi M; Osuka S; Weitzmann MN; Shoji M; Murata T
Int J Oncol; 2016 Aug; 49(2):812-22. PubMed ID: 27221776
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of regucalcin suppresses cell response for tumor necrosis factor-alpha or transforming growth factor-beta1 in cloned normal rat kidney proximal tubular epithelial NRK52E cells.
Nakagawa T; Yamaguchi M
J Cell Biochem; 2007 Apr; 100(5):1178-90. PubMed ID: 17063480
[TBL] [Abstract][Full Text] [Related]
16. Prolonged survival in hepatocarcinoma patients with increased regucalcin gene expression: HepG2 cell proliferation is suppressed by overexpression of regucalcin in vitro.
Yamaguchi M; Osuka S; Weitzmann MN; El-Rayes BF; Shoji M; Murata T
Int J Oncol; 2016 Oct; 49(4):1686-94. PubMed ID: 27633001
[TBL] [Abstract][Full Text] [Related]
17. The calcium channel agonist Bay K 8644 promotes the growth of human liver cancer HepG2 cells in vitro: suppression with overexpressed regucalcin.
Yamaguchi M; Murata T; Ramos JW
Mol Cell Biochem; 2020 Sep; 472(1-2):173-185. PubMed ID: 32591915
[TBL] [Abstract][Full Text] [Related]
18. The novel dithiocarbamate, DpdtC suppresses HER2-overexpressed cancer cells by up-regulating NDRG1 via inactivation of HER2-ERK 1/2 signaling.
Yang Y; Liu Y; Guo R; Fu Y; Zhang Z; Zhang P; Zhou P; Wang T; Huang T; Li X; Li C
Sci Rep; 2018 Feb; 8(1):3398. PubMed ID: 29467385
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Regucalcin Suppresses the Growth of Human Osteosarcoma Cells
Yamaguchi M; Murata T
Cancer Invest; 2020 Jan; 38(1):37-51. PubMed ID: 31868021
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the c-erbB-2 oncogene product in the EGF-induced cell motility of SK-OV-3 ovarian cancer cells.
Wiechen K; Karaaslan S; Dietel M
Int J Cancer; 1999 Oct; 83(3):409-14. PubMed ID: 10495435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
